Discover how precision biotherapeutics can transform healthcare in India by personalizing treatments based on genetic and ...

Genetic medicines-focused Scribe Therapeutics is racing toward the clinic on the heels of a preclinical data drop for three ...

Scribe Therapeutics Inc. ("Scribe"), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care ...

Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems for the acceleration of partners' clinical development, recently presented its Next-Generation LNP advancements, a ...